Purchase Order 75N92025P00372

Award Date 9/11/25
Potential Completion Date 11/11/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $13,265.25 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the supply of antibodies and kits to support cell isolation research that may affect the immune system. Biolegend is a specialized supplier of products used in immunology, oncology, neuroscience, and cell biology...
This federal contract award is for BIOLEGEND TOTALSEQ-C REAGENTS with a ceiling value of $48,965.00. The contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and scientific research products located in San Diego, California. The contract is a firm fixed-price purchase order with an ultimate completion date of October 9, 2025. The...
This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and research products. The $23,028.75 contract is for the provision of CITEsequencing kits to support staining and labeling research being conducted by the NHLBI DIR Wiley Lab. The award has no set-aside designation and is not associated with a larger...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products for life science research and drug discovery. The $3,500.51 contract is to provide a variety of specialized reagents and products, such as oligonucleotide-tagged antibodies, TotalSeq antibody panels, and custom human antibody panels, to support research initiatives...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical research products. The contract, valued at $7,190.00, is for the delivery of antibodies. There is no set-aside designation for this contract. Biolegend, Inc. is the prime contractor and has not...
This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...
This $24,970 firm fixed price purchase order was awarded by the National Heart, Lung and Blood Institute of the National Institutes of Health to BioLegend, Inc., a medical division of Revvity Inc., to supply a custom human antibody panel. The solicitation requested TotalSeq-C Custom Human Panels consisting of 11 pouches with 5 reactions per pouch, for a total of 53 reactions. This antibody panel will support the Laboratory of Myeloid Malignancies' single-cell genomics and proteomics research...

This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other scientific research products based in San Diego, California. The $10,492.50 firm-fixed-price purchase order is for the delivery of Total-Seq antibody cocktails, which are mixtures of antibodies conjugated to DNA oligonucleotides used in the preparation of multi-omic single-cell libraries. This contract supports the NHLBI's Laboratory of Immune Regulatory Genomics and Epigenomics and does not have a small business set-aside designation. Biolegend, Inc. has a history of providing specialized research materials to various NIH institutes, including for COVID-19 investigations, immune response analysis, and studies on diseases like multiple sclerosis and cancer.

Generated 9/13/25, 9:48 AM